Home › Funds › TENOR CAPITAL MANAGEMENT Co., L.P. › HALO

TENOR CAPITAL MANAGEMENT Co., L.P. position in HALO

HALOZYME THERAPEUTICS INC · Health Care

TENOR CAPITAL MANAGEMENT Co., L.P. reported holding 37,827,000 shares of HALO (HALOZYME THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$55.6M, representing 1.03% of its reported portfolio and ranking #22 among its reported holdings. TENOR CAPITAL MANAGEMENT Co., L.P. has disclosed HALO holdings in 11 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)37.83M sh
Reported value held$55.61M
Portfolio Weight1.03%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How TENOR CAPITAL MANAGEMENT Co., L.P.'s HALO position evolved

TENOR CAPITAL MANAGEMENT Co., L.P. first disclosed a stake in HALO in Q3 2023 at 12,000,000 shares (US$10.19B). The position peaked in Q4 2024 at 22,500,000 shares, worth US$21.56B. Across 11 filings, TENOR CAPITAL MANAGEMENT Co., L.P. increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 37,827,000 shares valued at US$55.6M — a reduction of -17,199,000 shares quarter over quarter.. Notable position changes include a 38% trim in Q3 2025 (shares fell 8% over the following quarter), a 273% increase in Q4 2025 (shares fell 4% over the following quarter), a 39% increase in Q1 2026 (shares rose 21% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 12.00M $10.19B New
Q4 2023 12.00M $10.41B Hold
Q1 2024 15.00M $13.34B Add
Q2 2024 18.00M $17.19B Add
Q4 2024 22.50M $21.56B New
Q1 2025 17.00M $18.03B Reduce
Q2 2025 17.00M $16.95M Hold
Q3 2025 10.62M $14.98M Reduce
Q4 2025 39.63M $52.78M Add
Q1 2026 55.03M $71.00M Add
Q2 2026 37.83M $55.61M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About HALO and 13F data

HALO (HALOZYME THERAPEUTICS INC) is a Health Care company. 43 other funds we track also report a position in HALO — the largest reported positions include CONGRESS ASSET MANAGEMENT CO (US$251.9M), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (US$196.5M), SNYDER CAPITAL MANAGEMENT L P (US$187.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding HALO

All HALO fund holders →

FAQ

How long has TENOR CAPITAL MANAGEMENT Co., L.P. held HALO?

TENOR CAPITAL MANAGEMENT Co., L.P. has disclosed HALO holdings in 11 of the last 12 reported quarters, going back to Q3 2023.

What is TENOR CAPITAL MANAGEMENT Co., L.P.'s current position in HALO?

As of Q2 2026, TENOR CAPITAL MANAGEMENT Co., L.P. holds 37.83M shares of HALO (HALOZYME THERAPEUTICS INC), valued at $55.61M, representing 1.03% of its reported portfolio and ranking #22.

Has TENOR CAPITAL MANAGEMENT Co., L.P. been buying or selling HALO?

In the latest 13F filing (Q2 2026), TENOR CAPITAL MANAGEMENT Co., L.P. reduced its position in HALO. The position peaked in Q4 2024 at 22.50M shares.

Which other funds hold HALO?

Other major institutional holders of HALO include CONGRESS ASSET MANAGEMENT CO, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, SNYDER CAPITAL MANAGEMENT L P, among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.